A Medical Device Daily Staff Report

BioReference Laboratories (Elmwood Park, New Jersey) reported the approval by its board and the declaration of a forward two for one split of its common stock entitling each holder at the close of business on April 19 to receive one additonal share of the company's common stock for each share owned. Distribution of the additional shares is expected to be made around April 21.

"The announced stock split will meaningfully increase our outstanding shares and is consistent with our overall capital management strategy and our commitment to driving sustainable shareholder value," said CEO Marc Grodman, MD.

No Comments